Business Segments · Gain (Loss) on Portfolio Actions

Optum Rx — Gain (Loss) on Portfolio Actions

UnitedHealth Group Optum Rx — Gain (Loss) on Portfolio Actions remained flat by 0.0% to -$375.00M in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ4 2025

How to read this metric

A gain indicates successful divestiture of assets at a premium, while a loss suggests impairment or unfavorable terms during portfolio optimization.

Detailed definition

This metric represents the net financial impact resulting from strategic adjustments to the business segment's asset por...

Peer comparison

Similar to 'Net gain/loss on disposal of assets' or 'Non-operating portfolio adjustments' found in other large healthcare services or pharmacy benefit management firms.

Metric ID: unh_segment_optum_rx_gain_loss_on_portfolio_actions

Historical Data

1 years
 FY'25
Value-$1.50B

Frequently Asked Questions

What is UnitedHealth Group's optum rx — gain (loss) on portfolio actions?
UnitedHealth Group (UNH) reported optum rx — gain (loss) on portfolio actions of -$375.00M in Q4 2025.
What does optum rx — gain (loss) on portfolio actions mean?
The net profit or loss generated from selling or restructuring specific assets or business units within the segment.